close
Tech & Innovation
4 mins to read

Biotech venture capital investor honoured

Duncan Mackintosh’s role in New Zealand’s developing biotech sector recognised at the KiwiNet Awards.

Brandon Capital New Zealand head Duncan Mackintosh. Photo Sciencelens.

Maria Slade Thu, 28 Sep 2023

Veteran biotech investor Duncan Mackintosh has taken out the highest honour at this year’s KiwiNet Research Commercialisation Awards – the Commercialisation Icon for 2023.

Mackintosh, who heads the New Zealand operation of Australasian venture capital firm Brandon Capital, has helped shape the

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace
NZ Aviation News

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Aviation News - Monthly

NZ$14.95 / monthly

Already have an account? Login
Contact the Writer: maria@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Biotech venture capital investor honoured
Tech & Innovation,
101050